HealthEquity Affirms FY2027 Adj EPS Guidance of $4.66-$4.73 vs $4.72 Est; Raises FY2027 Sales Guidance from $1.410B-$1.420B to $1.411B-$1.421B vs $1.416B Est

Benzinga Newsdesk www.benzinga.com Negative 62.3%

Neg 62.3% Neu 0% Pos 0%

HealthEquity (NASDAQ:HQY) affirms FY2027 Adj EPS guidance from $4.66-$4.73 to $4.66-$4.73 vs $4.72 analyst estimate. Raises FY2027 sales outlook from $1.410 billion-$1.420 billion to $1.411 billion-$1.421 billion vs $1.416 billion estimate.